{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"authors":[{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""},"note":"","is_verified_user":true},{"name":"Melissa Khaw","affiliation":"University of Minnesota Twin-Cities","affiliation_url":null,"username":"melissa-khaw","link":null,"image":{"source":"/img/avatars/012.png","placeholder":"/img/avatars/012.png","webp_source":""},"note":"","is_verified_user":true},{"name":"Amanda Russell","affiliation":"University of Minnesota","affiliation_url":null,"username":"n4sle112z1t4vle1","link":null,"image":{"source":"https://lh3.googleusercontent.com/a/AEdFTp4XHfFESSi14gH5zs6PNOtUAjsxnltRmSx9GuaI=s96-c","placeholder":"https://lh3.googleusercontent.com/a/AEdFTp4XHfFESSi14gH5zs6PNOtUAjsxnltRmSx9GuaI=s96-c","webp_source":""},"note":"","is_verified_user":true}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_manage_keywords":true,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1694728476,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""},"badges":[{"id":4,"name":"Gold power author!","image":{"source":"/img/badges/gold.svg","placeholder":"/img/badges/gold.svg"}},{"id":5,"name":"Early adopter","image":{"source":"/img/badges/star.svg","placeholder":"/img/badges/star.svg"}},{"id":6,"name":"Science accelerator","image":{"source":"/img/badges/accelerator.svg","placeholder":"/img/badges/accelerator.svg"}}],"affiliations":[{"affiliation":"University of Minnesota","url":"pippa.r.kennedy@gmail.com","job_title":null,"is_default":true}]},"cross_cloud_origin":null,"description":"{\"blocks\":[{\"key\":\"8ip2k\",\"text\":\" An amalgamation of cell line data in the lab. Its origin and standard culture conditions.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","disclaimer":"","document":"","documents":null,"doi":"dx.doi.org/10.17504/protocols.io.rm7vz82o8vx1/v4","doi_status":1,"ethics_statement":"","fork_id":null,"fork_info":null,"forks":[],"funders":[{"funder_name":"Emily Whitehead Foundation","grant_id":""},{"funder_name":"Department of Defense","grant_id":"CA200922"}],"groups":[{"id":1821,"uri":"miller-group-cell-culture","title":"Miller Group - cell culture","is_public":false,"image":{"source":"https://s3.amazonaws.com/protocols-files/files/C209A8842A7F11ECAB100A58A9FEAC02-placeholder.png","placeholder":"https://s3.amazonaws.com/protocols-files/files/C209A8842A7F11ECAB100A58A9FEAC02-placeholder.png"},"tech_support":{"email":null,"phone":null,"use_email":false,"hide_contact":false,"url":null}}],"guid":"4C0C9ADD534911EEAD860A58A9FEAC02","guidelines":"","has_references":false,"has_step_reagents":false,"has_versions":true,"id":87814,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":false,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":1161919,"journal":null,"journals":[],"keywords":null,"last_modified":1718148850,"link":"","location":null,"manuscript_citation":"","materials":[{"guid":"","mol_weight":0,"name":"A549","linfor":"","url":"","sku":"CCL-185","cas_number":"","rrid":"CVCL_0023","public":0,"can_edit":1,"entries":null,"vendor":{"id":14,"name":"ATCC","link":"http://www.atcc.org/","is_requested":false,"image":{"source":"/img/vendors/placeholder.png","placeholder":"/img/vendors/placeholder.png"}}}],"materials_text":"{\"blocks\":[{\"key\":\"XIjBW\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","ownership_history":null,"parent_collections":[{"id":84864,"title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","title_html":null,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":null,"uri":"metabolic-programs-drive-function-of-therapeutic-n-cw48xgzw","published_on":0,"modified_on":0,"version_class":0,"version_id":0,"version_code":"","version_uri":"","created_on":1689108316,"categories":null,"type_id":0,"creator":{"name":"Pippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":null,"username":"pippa-r-kennedy","link":"","image":{"source":"/img/avatars/014.png","placeholder":"/img/avatars/014.png","webp_source":""}},"stats":null},{"id":101631,"title":"A tri-specific killer engager (TriKE) against mesothelin targets NK cells towards lung cancer","title_html":null,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":null,"uri":"a-tri-specific-killer-engager-trike-against-mesoth-dfg73jzn","published_on":0,"modified_on":0,"version_class":0,"version_id":1,"version_code":"","version_uri":"","created_on":1667416895,"categories":null,"type_id":0,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""}},"stats":null}],"parent_protocols":[],"peer_reviewed":false,"protocol_references":"","public":true,"public_fork_note":"","published_on":1718148850,"references":[],"related_equipments":[],"related_materials":[],"reserved_doi":"","retraction_reason":null,"samples":{},"shared_access_id":265,"show_comparison":true,"sign_info":null,"space_access":{"can_view":false,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":true,"can_get_doi":true,"can_share":false,"can_move":false,"can_move_outside":false,"can_transfer":false,"can_download":false,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"space_id":1842,"state_version_id":786,"stats":{"is_voted":false,"number_of_views":295,"number_of_steps":21,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":1,"number_of_equipments":0,"number_of_collections":2,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this protocol and it's working"},"steps":[{"id":1789552,"guid":"4C29F07B534911EEAD860A58A9FEAC02","previous_id":null,"previous_guid":null,"section":"\u003cp\u003eOverview\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"77o7t\",\"text\":\"All cells are maintained in humidified incubators at 37°C, 5% CO2, unless otherwise specified. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sub\",\"offset\":64,\"length\":1}],\"entityRanges\":[],\"data\":[]},{\"key\":\"ccg2k\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"8u2in\",\"text\":\"All cells are routinely tested for mycoplasma infection using a PCR-based test (Universal Mycoplasma Detection Kit, ATCC Cat. No. 30-1012K)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"6rfgq\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"fvf3t\",\"text\":\"Dates of purchase are provided. Aliquots of purchased cells lines are frozen at P0, P1 and P2 from original stocks and P2 are defrosted and used for experimentation as standard.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"3fk3h\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"5rhrv\",\"text\":\"Cell lines confirmed by short tandem repeat analysis are marked with *.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584373,"number":"1","cases":[],"critical":null},{"id":1789553,"guid":"4C2A5012534911EEAD860A58A9FEAC02","previous_id":1789552,"previous_guid":"4C29F07B534911EEAD860A58A9FEAC02","section":"\u003cp\u003eOverview\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"7jckf\",\"text\":\"Media for cell lines:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bejpg\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"856rr\",\"text\":\"R10: RPMI (Gibco Cat. No. 2240-089) + 10% fetal bovine serum (Gibco Cat. No. 26140079) + 100 U/mL Penicillin and Streptomycin (Gibco Cat. No. 15140122)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":4}],\"entityRanges\":[],\"data\":{}},{\"key\":\"14rhq\",\"text\":\"D10: DMEM (Corning Cat. No. MT10013CV) + 10% fetal bovine serum (Gibco Cat. No. 26140079) + 100 U/mL Penicillin and Streptomycin (Gibco Cat. No. 15140122)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":3}],\"entityRanges\":[],\"data\":{}},{\"key\":\"1jjgf\",\"text\":\"D10-SP (without sodium pyruvate): DMEM (Corning Cat. No. 10-017-CV) + 10% fetal bovine serum (Gibco Cat. No. 26140079) + 100 U/mL Penicillin and Streptomycin (Gibco Cat. No. 15140122).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":32}],\"entityRanges\":[],\"data\":{}},{\"key\":\"5frnu\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2tkug\",\"text\":\"Unless otherwise indicated, adherent cells are passaged using trypsin-EDTA (0.05%, Gibco Cat. No. 25300054). Some lines require 0.25% trypsin/1mM EDTA without Ca2+ Mg2+ (EMD Millipore, Cat. No. SM-2003-C), or this buffer diluted to 0.2% trypsin.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":161,\"length\":2},{\"style\":\"sup\",\"offset\":166,\"length\":2}],\"entityRanges\":[],\"data\":{}},{\"key\":\"icck\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5kv9v\",\"text\":\"Cells transfected with plasmid are maintained with blasticidin (Thermo Fischer Scientific, Cat. No. A1113903) or puromycin (Sigma Aldrich, Cat. No. P9620-10ML).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":51,\"length\":11},{\"style\":\"bold\",\"offset\":113,\"length\":9}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584374,"number":"2","cases":[],"critical":null},{"id":1789554,"guid":"4C2ACA53534911EEAD860A58A9FEAC02","previous_id":1789553,"previous_guid":"4C2A5012534911EEAD860A58A9FEAC02","section":"\u003cp\u003eLung\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"r1e6\",\"text\":\"Non-small cell lung cancers: \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"1ptt6\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"d1bc4\",\"text\":\"Lung adenocarcinomas: \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3f0dh\",\"text\":\"1. A549 (RRID:CVCL_0023) was purchased from the American Type Culture Collection (ATCC) in March 2019; grown in R10 and split 1/20 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"157ip\",\"text\":\"1A. *A549-GFP/luciferase (Gift of Daniel Vallera)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"enf49\",\"text\":\"1B. A549-NucLightRed (generated by lentiviral transduction from ATCC stocks; Michael Kaminski 2019) grown with puromycin selection for maintenance (0.5  μg/mL)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":152,\"length\":1}],\"data\":{}},{\"key\":\"4e6o\",\"text\":\"2. NCI-H322 (RRID:CVCL_1556; purchased May 2019, Sigma Aldrich) grown in R10 and split 1/3 to 1/6 twice per week. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"47cap\",\"text\":\"3. NCI-H522 (RRID: CVCL_1567) grown in R10 and split 1/3 to 1/6 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ep692\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4f98i\",\"text\":\"Large cell lung carcinoma: \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7i391\",\"text\":\"1. NCI-H460 (RRID:CVCL_0459; purchased June 2019, ATCC) grown in R10 and split 1/8 three times per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5lmq2\",\"text\":\"1A. *NCI-H460-GFP/luciferase (Gift of Daniel Vallera) as above but selected with blasticidin (100 μg/mL)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"tex_formula\",\"mutability\":\"MUTABLE\",\"data\":{\"formula\":\"\",\"guid\":\"\",\"id\":0}}}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584375,"number":"3","cases":[],"critical":null},{"id":1789555,"guid":"4C2B466A534911EEAD860A58A9FEAC02","previous_id":1789568,"previous_guid":"4C315079534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMesothelioma\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"39rmu\",\"text\":\"Pleural epithelioid mesothelioma:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ft4d9\",\"text\":\"1. NCI-H2452 (RRID:CVCL_1553)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4t351\",\"text\":\"2. NCI-H226 (RRID:CVCL_1544 ) obtained from Daniel Vallera in 2009.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"6ara7\",\"text\":\"3. *NCI-H2461-GFP/luciferase (Gift of Manish Patel) grown in R10 and split 1/20 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c323d\",\"text\":\"4. YOU (RRID:CVCL_N819; Gift of Raffit Hassan, 2021, see Li et al. http://www.ncbi.nlm.nih.gov/pubmed/15274292) grown in R10 and split 1/4 twice a week. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":67,\"length\":43}],\"data\":{}},{\"key\":\"5cb0s\",\"text\":\"5. HAY (RRID:CVCL_N813; Gift of Raffit Hassan, 2021, see Li et al. http://www.ncbi.nlm.nih.gov/pubmed/15274292) grown in R10 and split 1/4 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":1,\"offset\":67,\"length\":43}],\"data\":{}},{\"key\":\"6uhfi\",\"text\":\"5A. HAY-luciferase/GFP created by Blake Jacobson, Manish Patel's lab, 2021) grown in R10 with 10μg/mL blasticidin for selection of the GFP/luciferase.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4in8t\",\"text\":\"6. ORT (RRID:CVCL_N815; Gift of Raffit Hassan, 2021, see Li et al. http://www.ncbi.nlm.nih.gov/pubmed/15274292) grown in R10 and split 1/2 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":2,\"offset\":67,\"length\":43}],\"data\":{}},{\"key\":\"e0tc3\",\"text\":\"7. ROB (RRID:CVCL_N818; Gift of Raffit Hassan, 2021, see Li et al. http://www.ncbi.nlm.nih.gov/pubmed/15274292) grown in R10 and split 1/4 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":3,\"offset\":67,\"length\":43}],\"data\":{}},{\"key\":\"5n5k3\",\"text\":\"8. PET (RRID:CVCL_N816; Gift of Raffit Hassan, 2021, see Li et al. http://www.ncbi.nlm.nih.gov/pubmed/15274292) grown in R10 and split 1/2 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":4,\"offset\":67,\"length\":43}],\"data\":{}},{\"key\":\"3gisg\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7tlnt\",\"text\":\"Sarcomatoid mesothelioma:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"aa4ie\",\"text\":\"1. NCI-H2691 (RRID:CVCL_A551)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"d8jp0\",\"text\":\"2. *NCI-H2373 (RRID:CVCL_A533) grown in R10 and split 1/5 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3gsor\",\"text\":\"2A. *NCI-H2373-GFP/luciferase (Gift of Manish Patel) grown in R10 and split 1/5 twice per week. Selected with blasticidin (2 μg/mL).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"CC9ED85FD6E511ECB72E0A58A9FEAC02\",\"url\":\"http://www.ncbi.nlm.nih.gov/pubmed/15274292\"}},\"1\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"D5B5A4F9D6E511ECB72E0A58A9FEAC02\",\"url\":\"http://www.ncbi.nlm.nih.gov/pubmed/15274292\"}},\"2\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"D68EF644D6E511ECB72E0A58A9FEAC02\",\"url\":\"http://www.ncbi.nlm.nih.gov/pubmed/15274292\"}},\"3\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"D75D93DFD6E511ECB72E0A58A9FEAC02\",\"url\":\"http://www.ncbi.nlm.nih.gov/pubmed/15274292\"}},\"4\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"D8193E5AD6E511ECB72E0A58A9FEAC02\",\"url\":\"http://www.ncbi.nlm.nih.gov/pubmed/15274292\"}}}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584376,"number":"6","cases":[],"critical":null},{"id":1789556,"guid":"4C2BC34A534911EEAD860A58A9FEAC02","previous_id":1789557,"previous_guid":"4C2C3867534911EEAD860A58A9FEAC02","section":"\u003cp\u003eBreast\u003c/p\u003e","section_color":"#EA94FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"d514p\",\"text\":\"Triple negative breast adenocarcinoma:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"40tt3\",\"text\":\"1. MDA-MB-231 (RRID: CVCL_0062; purchased from ATCC, August 2021) cultured in D10. Treat with 0.25% trypsin for 1-2 min only and split 1/10 three times a week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584377,"number":"8","cases":[],"critical":null},{"id":1789557,"guid":"4C2C3867534911EEAD860A58A9FEAC02","previous_id":1789555,"previous_guid":"4C2B466A534911EEAD860A58A9FEAC02","section":"\u003cp\u003eLeukemia\u003c/p\u003e","section_color":"#E57785","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"bvqq6\",\"text\":\"Chronic myelogenous leukemia\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3uquj\",\"text\":\"1. *K562 (RRID:CVCL_0004; purchased March 2015, Cat. No. CCL-243, ATCC) cultured in R10, split down to 1x105 cells/mL three times per week. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":107,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"757va\",\"text\":\"1A. *K562-Nuclight Red (Gift of Fate Therapeutics, created using Incucyte NucLight Red Lentivirus Reagent, EF1a, Puro; Sartorius, Cat. No. 4625) expression maintained with 1 μg/mL puromycin.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4liac\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7sir\",\"text\":\"Acute myeloid leukemia\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"f3425\",\"text\":\"1. HL-60 (RRID:CVCL_0002; purchased from April 2017, Cat. No. CCL-240, ATCC) grown in R10, split down to 2x105 cells/mL two to three times per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":109,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"btne\",\"text\":\"1A. *HL-60-luciferase (no GFP)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3m9as\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"crnnj\",\"text\":\"Childhood acute monocytic leukemia\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"867j9\",\"text\":\"1. THP-1 (RRID:CVCL_0006; purchased December 2015, Cat. No. TIB-202, ATCC) cultured in R10 with 50µM β-mercaptoethanol. Split down to 2-4x105 cells/mL. Subculture when cell concentration reaches 8x105 cells/mL. Do not allow the cell concentration to exceed 1x106 cells/mL.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":140,\"length\":1},{\"style\":\"sup\",\"offset\":199,\"length\":1},{\"style\":\"sup\",\"offset\":261,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"ehvfi\",\"text\":\"2. MV-4-11 (RRID:CVCL_0064; purchased February 2015, Cat. No. CRL-9591, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"60gtr\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"1g6mt\",\"text\":\"Plasma cell myeloma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bb64h\",\"text\":\"1. MM1.S (RRID:CVCL_8792; purchased December 2021, Cat. No. CRL-2974, ATCC) cultured in R10. Scrape to split 1/2 twice or three times per week. Spin at 125g 5min.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4vfo4\",\"text\":\"1A. *MM1.S-NuclightRed (Gift of Fate Therapeutics)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584378,"number":"7","cases":[],"critical":null},{"id":1789558,"guid":"4C2CB0D1534911EEAD860A58A9FEAC02","previous_id":1789556,"previous_guid":"4C2BC34A534911EEAD860A58A9FEAC02","section":"\u003cp\u003eLymphoma\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"bvumu\",\"text\":\"Epstein-Barr virus-related Burkitt lymphoma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bred2\",\"text\":\"1. Raji (RRID:CVCL_0511; purchased March 2015, Cat. No. CCL-86, ATCC) cultured in R10, split down to 4 x105 cells/mL three times per week. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":106,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"4aiej\",\"text\":\"1A. *Raji-Nuclight Red (Gift of Fate Therapeutics, created using Incucyte NucLight Red Lentivirus Reagent, EF1a, Puro; Sartorius, Cat. No. 4625) expression maintained with 1μg/mL puromycin.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2hlmi\",\"text\":\"2. Daudi (RRID:CVCL_0008; purchased April 2018, Cat. No. CCL-213, ATCC) cultured in R10, split down to 3-5x105 cells/mL; should not exceed 3x106 cells/mL. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":109,\"length\":1},{\"style\":\"sup\",\"offset\":143,\"length\":1}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584379,"number":"9","cases":[],"critical":null},{"id":1789559,"guid":"4C2D27EE534911EEAD860A58A9FEAC02","previous_id":1789558,"previous_guid":"4C2CB0D1534911EEAD860A58A9FEAC02","section":"\u003cp\u003eGut\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"8sgle\",\"text\":\"Colon adenocarcinoma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5rklv\",\"text\":\"1. CaCO-2 (RRID: CVCL_0025) purchased from ATCC before 2016 (Schohl et al. Targeted Oncology, 2016, doi:10.1007/s11523-015-0391-8)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"afsj9\",\"text\":\"Cultured in Eagle's Minimum Essential Medium (ATCC Cat. No. 30-2003) + 20% fetal bovine serum (Gibco Cat. No. 26140079) + 100 U/mL Penicillin and Streptomycin (Gibco Cat. No. 15140122); split 1/2 once per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7ap71\",\"text\":\"2. *HT29 (RRID:CVCL_0320; purchase May 2022, Cat. HTB-38, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"14ve4\",\"text\":\"P0 to P2 were cultured in McCoy's 5A medium modified (30-2007, ATCC); P3 onwards grown in R10. All split 1/8 3 times per week, down to 40,000 cells/cm2.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":150,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"68bc7\",\"text\":\"2A. *HT29-Nuclight Red (Gift of Daniel Vallera, 2022) expression maintained in 0.5μg/mL puromycin.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2frg2\",\"text\":\"2B. *HT29-GFP/luciferase (Gift of Daniel Vallera, 2022) expression maintained in 10μg/mL blasticidin.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4bnq4\",\"text\":\"3. *T24 (Gift of Manish Patel's lab) grown in R10 and split 1/20 twice per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584380,"number":"10","cases":[],"critical":null},{"id":1789560,"guid":"4C2D9EB5534911EEAD860A58A9FEAC02","previous_id":1789559,"previous_guid":"4C2D27EE534911EEAD860A58A9FEAC02","section":"\u003cp\u003eEndometrium\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1a0d\",\"text\":\"Endometrial adenocarcinoma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"evqjf\",\"text\":\"1. Ishikawa 3-H-12 (same as ECC-1) sensitive\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"66epn\",\"text\":\"2. Ishikawa 3-H-12 (same as ECC-1) resistant\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"2pr2e\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584381,"number":"11","cases":[],"critical":null},{"id":1789561,"guid":"4C2E144E534911EEAD860A58A9FEAC02","previous_id":1789575,"previous_guid":"238EDAB63BEE4F50886BEB786908877A","section":"\u003cp\u003eNK cell lines\u003c/p\u003e","section_color":"#EA94FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"8sq0s\",\"text\":\"Malignant non-Hodgkin's lymphoma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bj45o\",\"text\":\"1. *NK-92 (RRID:CVCL_2142; Gift of Kerry Campbell, Philadelphia, 2018)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":26,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"8kejj\",\"text\":\"(see also Assessing IL-15 bioavailability - 'the bioassay') NK-92 are maintained in Alpha Minimum Essential Medium plus ribonucleosides and deoxyribonucleosides (12571, Gibco), β-mercaptoethanol (0.1mM, M7522, Sigma Aldrich), recombinant human IL-2 (100U/mL, NDC 65483-116-07, Prometheus), horse serum (12.5%, 26050088, Fisher Scientific), fetal bovine serum (12.5%, 26140079, Gibco), Penicillin and Streptomycin (100U/ml, 15140122, Gibco). Split down to 2x105 - 3x105 cells/mL three times per week.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":10,\"length\":48},{\"style\":\"sup\",\"offset\":459,\"length\":1},{\"style\":\"sup\",\"offset\":467,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"c2ebc\",\"text\":\"NK-92 freezing medium: 50% FBS; 40% NK92 media; 10% DMSO. Freeze no more than 5x106 cells/mL \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":82,\"length\":1}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584382,"number":"15","cases":[],"critical":null},{"id":1789562,"guid":"4C2E8B7A534911EEAD860A58A9FEAC02","previous_id":1789561,"previous_guid":"4C2E144E534911EEAD860A58A9FEAC02","section":"\u003cp\u003eT cell lines\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"coa3r\",\"text\":\"Childhood T lymphoblastic leukemia\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"u2n4\",\"text\":\"1. Jurkat clone E6.1 (RRID:CVCL_0367; purchased June 2015, Cat No. TIB-152, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":1584383,"number":"16","cases":[],"critical":null},{"id":1789563,"guid":"4C2F0150534911EEAD860A58A9FEAC02","previous_id":1789562,"previous_guid":"4C2E8B7A534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMiscellaneous\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"6firp\",\"text\":\"Mouse mast cell neoplasm \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"bkoui\",\"text\":\"1. P815 (ATCC Cat. No. TIB-64, purchased August 2017, RRID:CVCL_2154) cultured in D10; split down to 1 x105 cells/mL three times per week. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":106,\"length\":1}],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584384,"number":"17","cases":[],"critical":null},{"id":1789564,"guid":"4C2F7799534911EEAD860A58A9FEAC02","previous_id":1789563,"previous_guid":"4C2F0150534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMiscellaneous\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"2682k\",\"text\":\"Human Dermal Microvascular Endothelial Cells\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"domst\",\"text\":\"1. HDMEC (Sigma Aldrich Cat. No. S100-05A)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"94dtn\",\"text\":\"Human Microvascular Endothelial Cells - Lung\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"9fhhg\",\"text\":\"1. HMVEC-L (Lonza Cat. No. CC-2527)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"0","duration":0,"original_id":1584385,"number":"18","cases":[],"critical":null},{"id":1789565,"guid":"4C2FED8C534911EEAD860A58A9FEAC02","previous_id":1789564,"previous_guid":"4C2F7799534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMiscellaneous\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"13vei\",\"text\":\"Renal clear cell carcinoma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"28ve5\",\"text\":\"1. Caki-1 (RRID:CVCL_0234; purchased July 2018, Cat. No. HTB-46, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"aor4h\",\"text\":\"2. Caki-2 (RRID:CVCL_0235; purchased March 2020, Cat. No. HTB-47, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":1584386,"number":"19","cases":[],"critical":null},{"id":1789566,"guid":"4C3061D0534911EEAD860A58A9FEAC02","previous_id":1789565,"previous_guid":"4C2FED8C534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMiscellaneous\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"fbs57\",\"text\":\"Mouse fibroblast\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"6gbco\",\"text\":\"1. L cells (RRID:CVCL_4536; purchased February 2016, Cat. No. CRL-2648, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":1584387,"number":"20","cases":[],"critical":null},{"id":1789567,"guid":"4C30DA84534911EEAD860A58A9FEAC02","previous_id":1789566,"previous_guid":"4C3061D0534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMiscellaneous\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"7hb95\",\"text\":\"Osteosarcoma\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"1b1bo\",\"text\":\"1. U2OS (RRID:CVCL_0042; purchased March 2020, Cat. No. HTB-96, ATCC)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]},{\"key\":\"7gp2u\",\"text\":\"Note - you cannot treat this cell line effectively with mycoplasma removal agent (Cat. No. BUF035, BioRad)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":[]}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":1584388,"number":"21","cases":[],"critical":null},{"id":1789568,"guid":"4C315079534911EEAD860A58A9FEAC02","previous_id":1790236,"previous_guid":"3F47D2A5A04A419E8795432F1DDE170D","section":"\u003cp\u003eProstate\u003c/p\u003e","section_color":"#FFED92","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"70rld\",\"text\":\"Castration resistant prostate cancer (CRPC):\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"b1q71\",\"text\":\"1. LnCAP (RRID: CVCL_0395) grown in R10, harvest with 0.2% trypsin.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"eapi3\",\"text\":\"1A. LnCAP acclimated to grow in hypoxia (Gift of Xcell Biosciences)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"6ur0p\",\"text\":\"2. *C4-2\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"f4ejd\",\"text\":\"3. *C4-2B (Gift of Xcell Biosciences)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"129s7\",\"text\":\"3A. C4-2B acclimated to grow in hypoxia (Gift of Xcell Biosciences)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"98ouj\",\"text\":\"4. *PC3 (Gift of Xcell Biosciences)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5nfam\",\"text\":\"4A. PC3 acclimated to grow in hypoxia (Gift of Xcell Biosciences)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4pakr\",\"text\":\"4B. *PC3-NuclightRed (Gift of Scott Dehm)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ef6u3\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":1584389,"number":"5","cases":[],"critical":null},{"id":1789569,"guid":"4C31C4B8534911EEAD860A58A9FEAC02","previous_id":1789560,"previous_guid":"4C2D9EB5534911EEAD860A58A9FEAC02","section":"\u003cp\u003eHead and Neck \u003c/p\u003e","section_color":"#FFED92","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1tqo\",\"text\":\"Human papilloma virus-negative Head and Neck Squamous Cell Carcinomas (HNSCCs): \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2quf6\",\"text\":\"1. *Cal27 (RRID:CVCL_1107; Gift of Ramon Garcia-Escudero, Spain, received in 2021) cultured in 15 mL D10/T75, split 3 times a week at 0.1 mil. cells/ mL, harvested using 0.25% trypsin (3 mL for T75, 5 mL for T150) for 3.5 minutes. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5ijlr\",\"text\":\"1A. *Cal27-Nuclight Red (generated by Melissa Khaw, using Incucyte NucLight Red Lentivirus Reagent, EF1a, Puro; Sartorius, Cat. No. 4625, August 2021), puromycin selection at 1.5 μg/ mL.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4cobl\",\"text\":\"2. *Cal33 (RRID:CVCL_1108; Gift of Ramon Garcia-Escudero, Spain, received in 2021) cultured in 15mL D10/T75, split 3 times a week at 0.1 mil. cells/ mL, harvested using 0.25% trypsin (3 mL for T75, 5 mL for T150) for 3.5 minutes. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"cu3bh\",\"text\":\"2A. *Cal33-Nuclight Red (generated by Melissa Khaw, using Incucyte NucLight Red Lentivirus Reagent, EF1a, Puro; Sartorius, Cat. No. 4625, August 2021), puromycin selection at 1.5 μg/ mL.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":1622880,"number":"12","cases":[],"critical":null},{"id":1789570,"guid":"5A88BBF81E8F45EB8C83F3A428236F01","previous_id":1789569,"previous_guid":"4C31C4B8534911EEAD860A58A9FEAC02","section":"\u003cp\u003eOvarian\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"eb6ob\",\"text\":\"1. OVCAR3 (NCI, received March 2017)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"d4hgm\",\"text\":\"2. OVCAR4 (NCI, received March 2017)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"65ndj\",\"text\":\"3. OVCAR5 (NCI, received March 2017)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"1ln55\",\"text\":\"4. *OVCAR8 (NCI, received March 2017) Culture in R10. Seed at 11,000 cells/cm2 when subculturing.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"a685d\",\"text\":\"4A. OVCAR8-Nuclight Red (made in 2018 by Laura Bendzick and Caitlin Ryan)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"10bh3\",\"text\":\"5. *SK-OV-3 (NCI, received March 2017)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"13","cases":[],"critical":null},{"id":1789575,"guid":"238EDAB63BEE4F50886BEB786908877A","previous_id":1789570,"previous_guid":"5A88BBF81E8F45EB8C83F3A428236F01","section":"\u003cp\u003eBrain\u003c/p\u003e","section_color":"#E57785","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"cje77\",\"text\":\"1. *BT12 (Gift of Crystal Mackall) grown in D10 with Glutamax.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9g0rr\",\"text\":\"1A. *BT12 B7H3-knockout (Gift of Crystal Mackall; https://doi.org/10.1038/s41591-020-0821-8)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"944v\",\"text\":\"2. BT16\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bkhsu\",\"text\":\"3. LN229 (ATCC, received December 2023) Grown in D10. See complete subculture protocol here: https://www.atcc.org/products/crl-2611\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":93,\"length\":38}],\"data\":{}},{\"key\":\"fmkqu\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"9512E028BBA511EE9E0E0A58A9FEAC02\",\"url\":\"https://www.atcc.org/products/crl-2611\"}}}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"14","cases":[],"critical":null},{"id":1790236,"guid":"3F47D2A5A04A419E8795432F1DDE170D","previous_id":1789554,"previous_guid":"4C2ACA53534911EEAD860A58A9FEAC02","section":"\u003cp\u003eMelanoma\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1pcjv\",\"text\":\"SK-Mel-3 (purchased from ATCC, 2022)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"672b0\",\"text\":\"CHL-2 (purchased from ATCC, 2022)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":87814,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"4","cases":[],"critical":null}],"template_id":1,"title":"Cell line information","title_html":"Cell line information","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0,"read_only":0},{"id":2,"type_id":3,"name":"mL","can_manage":0,"read_only":0},{"id":3,"type_id":3,"name":"L","can_manage":0,"read_only":0},{"id":4,"type_id":3,"name":"µg","can_manage":0,"read_only":0},{"id":5,"type_id":3,"name":"mg","can_manage":0,"read_only":0},{"id":6,"type_id":3,"name":"g","can_manage":0,"read_only":0},{"id":7,"type_id":3,"name":"kg","can_manage":0,"read_only":0},{"id":8,"type_id":3,"name":"ng","can_manage":0,"read_only":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0,"read_only":0},{"id":10,"type_id":24,"name":"°C","can_manage":0,"read_only":0},{"id":11,"type_id":24,"name":"°К","can_manage":0,"read_only":0},{"id":12,"type_id":24,"name":"°F","can_manage":0,"read_only":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0,"read_only":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0,"read_only":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0,"read_only":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0,"read_only":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0,"read_only":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0,"read_only":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0,"read_only":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0,"read_only":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":1},{"id":22,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0,"read_only":0},{"id":24,"type_id":3,"name":"μV","can_manage":0,"read_only":0},{"id":25,"type_id":3,"name":"ms","can_manage":0,"read_only":0},{"id":26,"type_id":3,"name":"pg","can_manage":0,"read_only":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0,"read_only":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0,"read_only":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0,"read_only":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0,"read_only":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0,"read_only":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0,"read_only":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0,"read_only":0},{"id":34,"type_id":30,"name":"x g","can_manage":0,"read_only":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0,"read_only":0},{"id":200,"type_id":32,"name":"cm","can_manage":0,"read_only":0},{"id":201,"type_id":32,"name":"mm","can_manage":0,"read_only":0},{"id":202,"type_id":32,"name":"µm","can_manage":0,"read_only":0},{"id":203,"type_id":32,"name":"nm","can_manage":0,"read_only":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0,"read_only":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0,"read_only":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0,"read_only":0},{"id":207,"type_id":3,"name":"V","can_manage":0,"read_only":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0,"read_only":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0,"read_only":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0,"read_only":0}],"uri":"cell-line-information-czzex73e","url":"https://www.protocols.io/view/cell-line-information-czzex73e","version_class":36002,"version_data":{"id":3,"code":"czzex73e","version_class":36002,"parent_id":76224,"parent_uri":"cell-line-information-cnn8vdhw","is_same_owner":true,"is_parent_public":true,"has_pending_merge_request":false,"has_approved_merge_request":true,"merge_request":{"id":2772,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""}},"created_on":1718145465,"can_manage":true}},"version_id":3,"version_uri":"cell-line-information-rm7vz82o8vx1/v4","versions":[{"id":36002,"title":"Cell line information","title_html":"Cell line information","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.rm7vz82o8vx1/v1","uri":"cell-line-information-bfeajjae","published_on":1662056971,"modified_on":1662056971,"version_class":36002,"version_id":0,"version_code":"bfeajjae","version_uri":"cell-line-information-rm7vz82o8vx1/v1","created_on":1587498644,"categories":null,"type_id":1,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":72222,"title":"Cell line information","title_html":"Cell line information","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.rm7vz82o8vx1/v2","uri":"cell-line-information-cir6ud9e","published_on":1667461676,"modified_on":1667461676,"version_class":36002,"version_id":1,"version_code":"cir6ud9e","version_uri":"cell-line-information-rm7vz82o8vx1/v2","created_on":1667415217,"categories":null,"type_id":1,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":76224,"title":"Cell line information","title_html":"Cell line information","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.rm7vz82o8vx1/v3","uri":"cell-line-information-cnn8vdhw","published_on":1680164670,"modified_on":1680164670,"version_class":36002,"version_id":2,"version_code":"cnn8vdhw","version_uri":"cell-line-information-rm7vz82o8vx1/v3","created_on":1675268972,"categories":null,"type_id":1,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":87814,"title":"Cell line information","title_html":"Cell line information","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.rm7vz82o8vx1/v4","uri":"cell-line-information-czzex73e","published_on":1718148850,"modified_on":1718148850,"version_class":36002,"version_id":3,"version_code":"czzex73e","version_uri":"cell-line-information-rm7vz82o8vx1/v4","created_on":1694728476,"categories":null,"type_id":1,"creator":{"name":"Philippa R Kennedy","affiliation":"University of Minnesota","affiliation_url":"pippa.r.kennedy@gmail.com","username":"philippa-r-kennedy","link":"","image":{"source":"/img/avatars/018.png","placeholder":"/img/avatars/018.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}